Clinical impact of whole-body FDG-PET for evaluation of response and therapeutic decision-making of primary lymphoma of bone
Gespeichert in:
| Veröffentlicht in: | Annals of oncology 2005-08, Vol.16 (8), p.1401-1402 |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1402 |
|---|---|
| container_issue | 8 |
| container_start_page | 1401 |
| container_title | Annals of oncology |
| container_volume | 16 |
| creator | Park, Y.H. Kim, S. Choi, S.-J. Ryoo, B.-Y. Yang, S.H. Cheon, G.J. Choi, C.-W. Lim, S.M. Yoo, J.Y. Lee, S.-S. |
| description | |
| doi_str_mv | 10.1093/annonc/mdi234 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68067992</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0923753419549298</els_id><sourcerecordid>68067992</sourcerecordid><originalsourceid>FETCH-LOGICAL-c482t-3af4768dc69d2c39aa656404943a0259165b19ab43a874479c3123d44c2bbf713</originalsourceid><addsrcrecordid>eNp1kEFv1DAQRi0EosvCkSvyiVuoHTt2fERL261UQQ8FKi6WY09Y08RO7aSwEj--WWVFT5xGM_P06dND6C0lHyhR7NSEEIM97Z0vGX-GVrQSqqgJp8_RiqiSFbJi_AS9yvkXIUSoUr1EJ7SqJSF1vUJ_N50P3poO-34wdsSxxb93sYOiiW6Pzz9dFNdnN7iNCcOD6SYz-hgOUII8xJABm-DwuINkBphGb7ED6_MMFb258-HngR2S703a427fD7vYm8OtiQFeoxet6TK8Oc41-np-drPZFldfLi43H68Ky-tyLJhpuRS1s0K50jJljKgEJ1xxZkhZKSqqhirTzGstOZfKMloyx7ktm6aVlK3R-yV3SPF-gjzq3mcLXWcCxClrURMh1SxrjYoFtCnmnKDVx-qaEn3QrRfdetE98--OwVPTg3uij36fAn0e4c-_v0l3WkgmK729_aE_q2rLv91e6-8zLxceZh0PHpLO1kOw4HwCO2oX_X-qPALkrqEa</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68067992</pqid></control><display><type>article</type><title>Clinical impact of whole-body FDG-PET for evaluation of response and therapeutic decision-making of primary lymphoma of bone</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Park, Y.H. ; Kim, S. ; Choi, S.-J. ; Ryoo, B.-Y. ; Yang, S.H. ; Cheon, G.J. ; Choi, C.-W. ; Lim, S.M. ; Yoo, J.Y. ; Lee, S.-S.</creator><creatorcontrib>Park, Y.H. ; Kim, S. ; Choi, S.-J. ; Ryoo, B.-Y. ; Yang, S.H. ; Cheon, G.J. ; Choi, C.-W. ; Lim, S.M. ; Yoo, J.Y. ; Lee, S.-S.</creatorcontrib><identifier>ISSN: 0923-7534</identifier><identifier>EISSN: 1569-8041</identifier><identifier>DOI: 10.1093/annonc/mdi234</identifier><identifier>PMID: 15870088</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Adult ; Aged ; Bone Neoplasms - diagnostic imaging ; Bone Neoplasms - pathology ; Bone Neoplasms - therapy ; Decision Making ; Female ; Fluorodeoxyglucose F18 ; Humans ; Lymphoma - diagnostic imaging ; Lymphoma - pathology ; Lymphoma - therapy ; Male ; Middle Aged ; Neoplasm Staging ; Prognosis ; Radiopharmaceuticals ; Tomography, Emission-Computed ; Treatment Outcome ; Whole-Body Counting</subject><ispartof>Annals of oncology, 2005-08, Vol.16 (8), p.1401-1402</ispartof><rights>2005 European Society for Medical Oncology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c482t-3af4768dc69d2c39aa656404943a0259165b19ab43a874479c3123d44c2bbf713</citedby><cites>FETCH-LOGICAL-c482t-3af4768dc69d2c39aa656404943a0259165b19ab43a874479c3123d44c2bbf713</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27929,27930</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15870088$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Park, Y.H.</creatorcontrib><creatorcontrib>Kim, S.</creatorcontrib><creatorcontrib>Choi, S.-J.</creatorcontrib><creatorcontrib>Ryoo, B.-Y.</creatorcontrib><creatorcontrib>Yang, S.H.</creatorcontrib><creatorcontrib>Cheon, G.J.</creatorcontrib><creatorcontrib>Choi, C.-W.</creatorcontrib><creatorcontrib>Lim, S.M.</creatorcontrib><creatorcontrib>Yoo, J.Y.</creatorcontrib><creatorcontrib>Lee, S.-S.</creatorcontrib><title>Clinical impact of whole-body FDG-PET for evaluation of response and therapeutic decision-making of primary lymphoma of bone</title><title>Annals of oncology</title><addtitle>Ann Oncol</addtitle><subject>Adult</subject><subject>Aged</subject><subject>Bone Neoplasms - diagnostic imaging</subject><subject>Bone Neoplasms - pathology</subject><subject>Bone Neoplasms - therapy</subject><subject>Decision Making</subject><subject>Female</subject><subject>Fluorodeoxyglucose F18</subject><subject>Humans</subject><subject>Lymphoma - diagnostic imaging</subject><subject>Lymphoma - pathology</subject><subject>Lymphoma - therapy</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Neoplasm Staging</subject><subject>Prognosis</subject><subject>Radiopharmaceuticals</subject><subject>Tomography, Emission-Computed</subject><subject>Treatment Outcome</subject><subject>Whole-Body Counting</subject><issn>0923-7534</issn><issn>1569-8041</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kEFv1DAQRi0EosvCkSvyiVuoHTt2fERL261UQQ8FKi6WY09Y08RO7aSwEj--WWVFT5xGM_P06dND6C0lHyhR7NSEEIM97Z0vGX-GVrQSqqgJp8_RiqiSFbJi_AS9yvkXIUSoUr1EJ7SqJSF1vUJ_N50P3poO-34wdsSxxb93sYOiiW6Pzz9dFNdnN7iNCcOD6SYz-hgOUII8xJABm-DwuINkBphGb7ED6_MMFb258-HngR2S703a427fD7vYm8OtiQFeoxet6TK8Oc41-np-drPZFldfLi43H68Ky-tyLJhpuRS1s0K50jJljKgEJ1xxZkhZKSqqhirTzGstOZfKMloyx7ktm6aVlK3R-yV3SPF-gjzq3mcLXWcCxClrURMh1SxrjYoFtCnmnKDVx-qaEn3QrRfdetE98--OwVPTg3uij36fAn0e4c-_v0l3WkgmK729_aE_q2rLv91e6-8zLxceZh0PHpLO1kOw4HwCO2oX_X-qPALkrqEa</recordid><startdate>20050801</startdate><enddate>20050801</enddate><creator>Park, Y.H.</creator><creator>Kim, S.</creator><creator>Choi, S.-J.</creator><creator>Ryoo, B.-Y.</creator><creator>Yang, S.H.</creator><creator>Cheon, G.J.</creator><creator>Choi, C.-W.</creator><creator>Lim, S.M.</creator><creator>Yoo, J.Y.</creator><creator>Lee, S.-S.</creator><general>Elsevier Ltd</general><general>Oxford University Press</general><scope>6I.</scope><scope>AAFTH</scope><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20050801</creationdate><title>Clinical impact of whole-body FDG-PET for evaluation of response and therapeutic decision-making of primary lymphoma of bone</title><author>Park, Y.H. ; Kim, S. ; Choi, S.-J. ; Ryoo, B.-Y. ; Yang, S.H. ; Cheon, G.J. ; Choi, C.-W. ; Lim, S.M. ; Yoo, J.Y. ; Lee, S.-S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c482t-3af4768dc69d2c39aa656404943a0259165b19ab43a874479c3123d44c2bbf713</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Bone Neoplasms - diagnostic imaging</topic><topic>Bone Neoplasms - pathology</topic><topic>Bone Neoplasms - therapy</topic><topic>Decision Making</topic><topic>Female</topic><topic>Fluorodeoxyglucose F18</topic><topic>Humans</topic><topic>Lymphoma - diagnostic imaging</topic><topic>Lymphoma - pathology</topic><topic>Lymphoma - therapy</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Neoplasm Staging</topic><topic>Prognosis</topic><topic>Radiopharmaceuticals</topic><topic>Tomography, Emission-Computed</topic><topic>Treatment Outcome</topic><topic>Whole-Body Counting</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Park, Y.H.</creatorcontrib><creatorcontrib>Kim, S.</creatorcontrib><creatorcontrib>Choi, S.-J.</creatorcontrib><creatorcontrib>Ryoo, B.-Y.</creatorcontrib><creatorcontrib>Yang, S.H.</creatorcontrib><creatorcontrib>Cheon, G.J.</creatorcontrib><creatorcontrib>Choi, C.-W.</creatorcontrib><creatorcontrib>Lim, S.M.</creatorcontrib><creatorcontrib>Yoo, J.Y.</creatorcontrib><creatorcontrib>Lee, S.-S.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Park, Y.H.</au><au>Kim, S.</au><au>Choi, S.-J.</au><au>Ryoo, B.-Y.</au><au>Yang, S.H.</au><au>Cheon, G.J.</au><au>Choi, C.-W.</au><au>Lim, S.M.</au><au>Yoo, J.Y.</au><au>Lee, S.-S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical impact of whole-body FDG-PET for evaluation of response and therapeutic decision-making of primary lymphoma of bone</atitle><jtitle>Annals of oncology</jtitle><addtitle>Ann Oncol</addtitle><date>2005-08-01</date><risdate>2005</risdate><volume>16</volume><issue>8</issue><spage>1401</spage><epage>1402</epage><pages>1401-1402</pages><issn>0923-7534</issn><eissn>1569-8041</eissn><cop>England</cop><pub>Elsevier Ltd</pub><pmid>15870088</pmid><doi>10.1093/annonc/mdi234</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0923-7534 |
| ispartof | Annals of oncology, 2005-08, Vol.16 (8), p.1401-1402 |
| issn | 0923-7534 1569-8041 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_68067992 |
| source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
| subjects | Adult Aged Bone Neoplasms - diagnostic imaging Bone Neoplasms - pathology Bone Neoplasms - therapy Decision Making Female Fluorodeoxyglucose F18 Humans Lymphoma - diagnostic imaging Lymphoma - pathology Lymphoma - therapy Male Middle Aged Neoplasm Staging Prognosis Radiopharmaceuticals Tomography, Emission-Computed Treatment Outcome Whole-Body Counting |
| title | Clinical impact of whole-body FDG-PET for evaluation of response and therapeutic decision-making of primary lymphoma of bone |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-12T18%3A22%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20impact%20of%20whole-body%20FDG-PET%20for%20evaluation%20of%20response%20and%20therapeutic%20decision-making%20of%20primary%20lymphoma%20of%20bone&rft.jtitle=Annals%20of%20oncology&rft.au=Park,%20Y.H.&rft.date=2005-08-01&rft.volume=16&rft.issue=8&rft.spage=1401&rft.epage=1402&rft.pages=1401-1402&rft.issn=0923-7534&rft.eissn=1569-8041&rft_id=info:doi/10.1093/annonc/mdi234&rft_dat=%3Cproquest_cross%3E68067992%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=68067992&rft_id=info:pmid/15870088&rft_els_id=S0923753419549298&rfr_iscdi=true |